Evidence map›Paper›PMID 34755596›Full record

ReviewDeutsches Arzteblatt international2021

The Evaluation of Iron Deficiency and Iron Overload

Norbert Gattermann, Martina U Muckenthaler, Andreas E Kulozik, Georgia Metzgeroth, Jan Hastka

Open access · greenAbstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Norbert GattermannDepartment of Haematology, Oncology and Clinical Immunology, Düsseldorf University Hospital; Department of Pediatric Oncology, Hematology, and Immunology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, German Center for Cardiovascular Diseases, Partner Heidelberg; Department of Pediatric Oncology, Hematology, and Immunology, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital; III. Department of Hematology and Oncology, University Hospital Mannheim.
Martina U Muckenthaler
Andreas E Kulozik
Georgia Metzgeroth
Jan Hastka
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the western world, 10-15% of women of child-bearing age suffer from iron-deficiency anemia. Iron overload due to chronic treatment with blood transfusions or hereditary hemochromatosis is much rarer.

methodsThis review is based on pertinent publications retrieved by a selective search on the pathophysiology, clinical features, and diagnostic evaluation of iron deficiency and iron overload.

resultsThe main causes of iron deficiency are malnutrition and blood loss. Its differential diagnosis includes iron-refractory iron deficiency anemia (IRIDA), a rare congenital disease in which the hepcidin level is pathologically elevated, as well as the more common anemia of chronic disease (anemia of chronic inflammation), in which increased amounts of hepcidin are formed under the influence of interleukin-6 and enteric iron uptake is blocked as a result. Iron overload comes about through long-term transfusion treatment or a congenital disturbance of iron metabolism (hemochromatosis). Its diagnostic evaluation is based on clinical and laboratory findings, imaging studies, and specific mutation analyses.

conclusionOur improving understanding of the molecular pathophysiology of iron metabolism aids in the evaluation of iron deficiency and iron overload and may in future enable treatment not just with iron supplementation or iron chelation, but also with targeted pharmacological modulation of the hepcidin regulatory system.

Indexed as

AnemiaAnemia, Iron-DeficiencyIron DeficienciesIron OverloadFemaleHumansIronIron

Identifiers

PMID34755596
PMCPMC8941656
OpenAlexW3211818783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.